Potassium Iodide → HCID 18538919, compound

HRID 1394377Notes

Reaction equation

HRID 1394377 reaction equation
C(O[C:6]([N:8]1[CH2:13][CH2:12][CH:11]([S:14][C:15]2[S:16][C:17]3[CH:23]=[CH:22][CH:21]=[CH:20][C:18]=3[N:19]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.FC(F)(F)C(O)=O.[C:31]([N:34]1[CH2:39][CH2:38][CH:37]([C:40]([N:42]([C:47]2[CH:52]=[CH:51][CH:50]=[C:49]([Cl:53])[CH:48]=2)[CH2:43][CH2:44]C[Cl:46])=[O:41])[CH2:36][CH2:35]1)(=[O:33])[CH3:32].C(=O)([O-])[O-].[K+].[K+].[I-].[K+]>ClCCl.C(OCC)(=O)C>[ClH:46].[C:31]([N:34]1[CH2:39][CH2:38][CH:37]([C:40]([N:42]([C:47]2[CH:52]=[CH:51][CH:50]=[C:49]([Cl:53])[CH:48]=2)[CH2:43][CH2:44][CH2:6][N:8]2[CH2:9][CH2:10][CH:11]([S:14][C:15]3[S:16][C:17]4[CH:23]=[CH:22][CH:21]=[CH:20][C:18]=4[N:19]=3)[CH2:12][CH2:13]2)=[O:41])[CH2:36][CH2:35]1)(=[O:33])[CH3:32]

Participants

8

Procedure

To a solution of 1-tert-butoxycarbonyl-4-(2-benzothiazolylthio)piperidine (505 mg, 1.44 mmol) in dry dichloromethane (4 ml) was added trifluoroacetic acid (4 ml) and stirred at room temperature for 30 min. After the solvent was removed in vacuo, the residue was dissolved in methanol (4 ml) and evaporated. The residue was dissolved in dry acetonitrile (12 ml) followed by addition of 1-acetyl-N-(3-chlorophenyl)-N-(3-chloropropyl)-4-piperidinecarboxamide (400 mg, 1.12 mmol), potassium carbonate (0.77 g, 5.6 mmol), and potassium iodide (186 mg, 1.12 mmol). After stirred at 80° C. for 8 h, the mixture was diluted with ethyl acetate (60 ml), washed with brine (60 ml), dried over anhydrous magnesium sulfate, and evaporated. The residue was purified by preparative HPLC eluting water-acetonitrile containing 0.1% TFA. To the TFA salt was added 5% aqueous solution of potassium carbonate, extracted with ethyl acetate (30 ml), washed with brine, dried over anhydrous magnesium sulfate, and evaporated. The residue dissolved in ethyl acetate (20 ml) was treated with 4N hydrogen chloride in ethyl acetate (0.72 ml). After the solvent was removed in vacuo, the residue was washed with ether and dried in vacuo to give the title compound (230 mg, 34%) as a white solid.

Workup

  1. customAfter the solvent was removed in vacuo
  2. dissolutionthe residue was dissolved in methanol (4 ml)
  3. customevaporated
  4. dissolutionThe residue was dissolved in dry acetonitrile (12 ml)
  5. stirringAfter stirred at 80° C. for 8 h
  6. washwashed with brine (60 ml)
  7. dry with materialdried over anhydrous magnesium sulfate
  8. customevaporated
  9. customThe residue was purified by preparative HPLC
  10. washeluting water-acetonitrile containing 0.1% TFA
  11. additionTo the TFA salt was added 5% aqueous solution of potassium carbonate
  12. extractionextracted with ethyl acetate (30 ml)
  13. washwashed with brine
  14. dry with materialdried over anhydrous magnesium sulfate
  15. customevaporated
  16. dissolutionThe residue dissolved in ethyl acetate (20 ml)
  17. additionwas treated with 4N hydrogen chloride in ethyl acetate (0.72 ml)
  18. customAfter the solvent was removed in vacuo
  19. washthe residue was washed with ether
  20. customdried in vacuo

Sources & evidence

ORD record
ord-b6059b2843e54f108491f8e7caa96408
Source dataset
uspto-grants-2008_03
Patent number
US07348324B2

Reaction notes

Loading…